Dr. Kathleen M Riley is a pharmacist who is specialized in Pharmacotherapy in Knoxville, Tennessee. Patients can reach her at K-mart Pharmacy #7460, 6906 Manardville Pike Ne, Knoxville or contact her on 865-922-7443. Active license number of Dr. Kathleen M Riley is 22508 for Pharmacotherapy in Tennessee. Dr. Kathleen M Riley is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Kathleen M Riley speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Kathleen M Riley are as mentioned below.
NPI Number:
1740498088
NPI Enumeration Date:
18 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kathleen M Riley are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
22508
Tennessee
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3800 Oak Valley Dr, Apt#125 Knoxville, Tennessee
Zip:
37918-5176
Phone Number:
570-313-9965
Fax Number:
--
Patients can reach Dr. Kathleen M Riley at K-mart Pharmacy #7460, 6906 Manardville Pike Ne, Knoxville, Tennessee or can call on phone at 865-922-7443.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.